ischemic heart disease. Other current complications following acute myocardial infarction
Conditions
Interventions
Treatment - Drugs
Intervention group 1: 0.1mg/kg Ephedrine bulus dose
Intervention group 2: 2 µ/kg Ephedrine
Intervention 1: Intervention group 1: 0.1mg/kg Ephedrine bulus dose. Intervention 2: Intervention group 2: 2 µ/kg Ephedrine.
Sponsors
Vice-chancellor for research -Shaid Sadoughi University of Medical Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: all patients undergoing for Off-pump coronary artery bypass graft surgery. exclusion criteria: history of liver and renal diseases? history of previous neurologic disease and CVA? EF<40%
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cerebral oxygenation. Timepoint: before and after recieving vasoconstrictor. Method of measurement: INVOS (Invos 5100 somanetic Corp, Tory, MI, usa ).;Cerebral oxygenation. Timepoint: before, during and after CX graft. Method of measurement: INVOS (Invos 5100 somanetic Corp, Tory, MI, usa ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean heart rate. Timepoint: befor induction, before and after recieving first constrictor,before and after recieving second constrictor. Method of measurement: ECG.;Mean arterial blood pressure. Timepoint: befor induction, before and after recieving first constrictor,before and after recieving second constrictor. Method of measurement: sphygmometer.;Mean O2 SATURATION. Timepoint: befor induction, before and after recieving first constrictor,before and after recieving second constrictor. Method of measurement: pulse oximetery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Hassan Abdollahi
Shaid Sadoughi University of Medical Science
Outcome results
None listed